tobramycin
treatment
pseudomonas
aeruginosa
infection
cystic
fibrosis
tobramycin
treatment
chronic
pulmonary
infection
caused
pseudomonas
aeruginosa
child
cystic
fibrosis
evaluated
initially
patient
received
recommended
dose
mg
hour
dose
increased
mg
hour
approximately
mg
kg
hour
higher
dosage
administered
intramuscularly
patient
eight
received
additional
therapy
aerosol
containing
tobramycin
therapy
possible
eradicate
p
aeruginosa
respiratory
tract
patient
discontinuing
therapy
p
aeruginosa
occurred
patient
within
one
month
patient
showed
clinical
improvement
relation
therapy
toxic
allergic
side
effect
observed
